Tag: nuclear imaging for neuroendocrine tumors
Dr. Lale Kostakoglu-Shields to Be Featured Guest for Luncheon with the Experts
Lale Kostakoglu-Shields, MD, MPH, a nuclear medicine expert, will be the featured guest for CCF’s Luncheon with the Experts on Thursday, April 15, 2021 from 12 noon to 1 pm, Eastern Time. Dr. Kostakoglu-Shields is a professor of radiology and medical…
READ MORE
Dr. Ebrahim Delpassand to be Featured Guest for CCF’s Luncheon with the Experts
Ebrahim S. Delpassand, MD, FACNM, Chairman and Medical Director at Excel Diagnostics & Nuclear Oncology Center in Houston, Texas and founder, Chairman of the Board, and CEO of Radiomedix in Houston, will be the featured guest for Luncheon with the…
READ MORE
First Northeastern Facility Offers Gallium-68 DOTATOC PET/CT Imaging for Carcinoid and Neuroendocrine Cancer Patients
When Brian Hakimian had the 68Gallium DOTATOC PET/CT scan at the Icahn School of Medicine, Mount Sinai in New York City on January 14, 2015, he became the first carcinoid patient to undergo this novel imaging test at a northeastern facility. Now in clinical…
READ MORE
Carcinoid Cancer Foundation Awards Grant to Stanford University
The Carcinoid Cancer Foundation in White Plains, New York has awarded a grant of more than $65,000.00 to Stanford University in California to expand access to its Gallium-68 (Ga-68) DOTA-TATE PET/CT program for carcinoid and neuroendocrine tumor (NET)…
READ MORE